Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) Director Mark J. Rubash sold 1,709 shares of the firm’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $380.00, for a total value of $649,420.00. Following the completion of the transaction, the director now owns 16,051 shares in the company, valued at approximately $6,099,380. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Intuitive Surgical Stock Up 1.5 %
Shares of NASDAQ ISRG opened at $388.65 on Wednesday. The business’s 50 day moving average is $385.34 and its two-hundred day moving average is $351.97. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The firm has a market cap of $137.86 billion, a price-to-earnings ratio of 70.15, a PEG ratio of 4.93 and a beta of 1.39.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the business earned $1.00 EPS. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.
Institutional Trading of Intuitive Surgical
Wall Street Analyst Weigh In
A number of research analysts have weighed in on the company. Stifel Nicolaus raised their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a report on Wednesday, January 24th. BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Wells Fargo & Company increased their price target on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a report on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $396.17.
Read Our Latest Report on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Garmin Navigates to New Highs Driven By Wearables Trend
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- How Can Investors Benefit From After-Hours Trading
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.